Contact Lens & Anterior Eye
Volume 31, Issue 2 , Pages 73-80 , April 2008

Clinical efficacy of amniotic membrane transplantation in the treatment of various ocular surface diseases

  • Jung Hyun Park

      Affiliations

    • Department of Ophthalmology, Seoul National University College of Medicine, Republic of Korea
    • ,
  • Jin Wook Jeoung

      Affiliations

    • Department of Ophthalmology, Seoul National University College of Medicine, Republic of Korea
    • ,
  • Won Ryang Wee

      Affiliations

    • Department of Ophthalmology, Seoul National University College of Medicine, Republic of Korea
    • Seoul Artificial Eye Center, Clinical Research Institute, Seoul National University Hospital, Republic of Korea
    • ,
  • Jin Hak Lee

      Affiliations

    • Department of Ophthalmology, Seoul National University College of Medicine, Republic of Korea
    • Seoul Artificial Eye Center, Clinical Research Institute, Seoul National University Hospital, Republic of Korea
    • ,
  • Mee Kum Kim

      Affiliations

    • Department of Ophthalmology, Seoul National University College of Medicine, Republic of Korea
    • Seoul Artificial Eye Center, Clinical Research Institute, Seoul National University Hospital, Republic of Korea
    • Corresponding Author InformationCorresponding author at: Department of Ophthalmology, Seoul National University College of Medicine, #28 Yongon-dong, Chongno-gu, Seoul 110-744, Republic of Korea. Tel.: +82 2 2072 2438; fax: +82 2 741 3187.
    • ,
  • Jae Lim Lee

      Affiliations

    • Valued Eye Clinic, Republic of Korea

References 

  1. de Rotth A. Plastic repair of conjunctival defects with fetal membrane. Arch Ophthalmol. 1940;23:522–525
  2. Kim JC, Tseng SC. Transplantation of preserved human amniotic membrane for surface reconstruction in severely damaged rabbit corneas. Cornea. 1995;14:473–484
  3. Grueterich M, Espana EM, Tseng SC. Ex vivo expansion of limbal epithelial stem cells: amniotic membrane serving as a stem cell niche. Surv Ophthalmol. 2003;48:631–646
  4. Prabhasawat P, Tesavibul N, Komolsuradej W. Single and multilayer amniotic membrane transplantation for persistent corneal epithelial defect with and without stromal thinning and perforation. Br J Ophthalmol. 2001;85:1455–1463
  5. Shin KS, Chung IY, Seo SW. The effect of amniotic membrane transplantation for corneal ulcer and ocular surface diseases. J Korean Ophthalmol Soc. 2003;44:1305–1310
  6. Anderson DF, Prabhasawat P, Alfonso E, Tseng SC. Amniotic membrane transplantation after the primary surgical management of band keratopathy. Cornea. 2001;20:354–361
  7. Espana EM, Crueterich M, Sandoval H, Solomon A, Alfonso E, Karp CL, et al. Amniotic membrane transplantation for bullous keratopathy in eyes with poor visual potential. J Cataract Refract Surg. 2003;29:279–284
  8. Tang GG, Ahn HB, Park WC. The clinical effects of dye-amniotic membrane transplantation on bullous keratopathy. J Korean Ophthalmol Soc. 2003;44:1741–1747
  9. Choi YS, Kim JY, Wee WR, Lee JH. Effect of application of human amniotic membrane on rabbit corneal wound healing after excimer laser photorefractive keratectomy. Cornea. 1998;17:389–395
  10. Woo HM, Kim HS, Kweon OK, Kim DY, Nam DC, Kim JH. Effects of amniotic membrane on epithelial wound healing and stromal remodeling after excimer laser keratectomy in rabbit cornea. Br J Ophthalmol. 2001;85:345–349
  11. Paridaens D, Beekhuis H, van Den Bosch W, Remever L, Melles G. Amniotic membrane transplantation in the management of conjunctival malignant melanoma and primary acquired melanosis with atypia. Br J Ophthalmol. 2001;85:658–661
  12. Espana EM, Prabhasawat P, Grueterich M, Solomon A, Tseng SC. Amniotic membrane transplantation for reconstruction after excision of large ocular surface neoplasias. Br J Ophthalmol. 2002;86:640–645
  13. Ti SE, Tseng SC. Management of primary and recurrent pterygium using amniotic membrane transplantation. Curr Opin Ophthalmol. 2002;13:204–212
  14. Shimazaki J, Kosaka K, Shimmura S, Tsubota K. Amniotic membrane transplantation with conjunctival autograft for recurrent pterygium. Ophthalmology. 2003;110:119–124
  15. Tseng SC, Prabhasawat P, Lee SH. Amniotic membrane transplantation for conjunctival surface reconstruction. Am J Ophthalmol. 1997;124:765–774
  16. Jain S, Rastogi A. Evaluation of the outcome of amniotic membrane transplantation for ocular surface reconstruction in symblepharon. Eye. 2004;18:1251–1257
  17. Tamhane A, Vajpayee RB, Biswas NR, Pandey RM, Sharma N, Titiyal JS, et al. Evaluation of amniotic membrane transplantation as an adjunct to medical therapy as compared with medical therapy alone in acute ocular burns. Ophthalmology. 2005;112:1963–1969
  18. Gomes JA, dos Santos MS, Cunha MC, Mascaro VL, Barros Lde N, de Sousa LB. Amniotic membrane transplantation for partial and total limbal stem cell deficiency secondary to chemical burn. Ophthalmology. 2003;110:466–473
  19. Tseng SC, Prabhasawat P, Barton K, Gray T, Meller D. Amniotic membrane transplantation with or without limbal allografts for corneal surface reconstruction in patients with limbal stem cell deficiency. Arch Ophthalmol. 1998;116:431–441
  20. Ucakhan OO, Koklu G, Firat E. Nonpreserved human amniotic membrane transplantation in acute and chronic chemical eye injuries. Cornea. 2002;21:169–172
  21. Nakamura T, Yoshitani M, Rigby H, Fullwood NJ, Ito W, Inatomi T, et al. Sterilized, freeze-dried amniotic membrane: a useful substrate for ocular surface reconstruction. Invest Ophthalmol Vis Sci. 2004;45:93–99
  22. Grueterich M, Espana EM, Tseng SC. Modulation of keratin and connexin expression in limbal epithelium expanded on denuded amniotic membrane with and without a 3T3 fibroblast feeder layer. Invest Ophthalmol Vis Sci. 2003;44:4230–4236
  23. Koizumi N, Rigby H, Fullwood NJ, Kawasaki S, Tanioka H, Koizumi K, et al. Comparison of intact and denuded amniotic membrane as a substrate for cell-suspension culture of human limbal epithelial cells. Graefes Arch Clin Exp Ophthalmol. 2007;245:123–134
  24. Nakamura T, Inatomi T, Sekiyama E, Ang LP, Yokoi N, Kinoshita S. Novel clinical application of sterilized, freeze-dried amniotic membrane to treat patients with pterygium. Acta Ophthalmol Scand. 2006;84:401–405
  25. Hick S, Demers PE, Brunette I, La C, Mabon M, Duchesne B. Amniotic membrane transplantation and fibrin glue in the management of corneal ulcers and perforations: a review of 33 cases. Cornea. 2005;24:369–377
  26. Meller D, Pires RT, Mack RJ, Fiqueiredo F, Heiligenhaus A, Park WC, et al. Amniotic membrane transplantation for acute chemical or thermal burns. Ophthalmology. 2000;107:980–989
  27. Hanada K, Shimazaki J, Shimmura S, Tsubota K. Multilayered amniotic membrane transplantation for severe ulceration of the cornea and sclera. Am J Ophthalmol. 2001;131:324–331
  28. Jeoung JW, Yoon YM, Lee JL, Wee WR, Lee JH, Kim MK. The effect of amniotic membrane transplantation on the treatment of necrotizing scleritis after pterygium excision. J Korean Ophthalmol Soc. 2004;45:1981–1988
  29. Khokhar S, Natung T, Sony P, Sharma N, Agaral N, Vajpay RB. Amniotic membrane transplantation in refractory neurotrophic corneal ulcers: a randomized, controlled clinical trial. Cornea. 2005;24:654–660
  30. Chen HJ, Pires RT, Tseng SC. Amniotic membrane transplantation for severe neurotrophic corneal ulcers. Br J Ophthalmol. 2000;84:826–833
  31. Mekia LF, Santamaria JL, Acosta C. Symptomatic management of postoperative bullous keratopathy with nonpreserved human amniotic membrane. Cornea. 2002;21:342–345
  32. Srinivas S, Mavrikakis E, Jenkins C. Amniotic membrane transplantation for painful bullous keratopathy. Eur J Ophthalmol. 2007;17:7–10
  33. Koizumi N, Inatomi T, Sotozono C, Fullwood NJ, Quantock AJ, Kinoshita S. Growth factor mRNA and protein in preserved human amniotic membrane. Curr Eye Res. 2000;20:173–177
  34. Tang GF, Yan YM, Wang YL, Cui XC, Zhang YM, Fu XX, et al. Comparison between the effects of ocular surface reconstruction by fresh and preserved amniotic membranes. J Clin Rehab Tissue Eng Res. 2007;16:3122–3123
  35. Luanratanakorn P, Ratanapakorn T, Suwan-Apichon O, Chuuck RS. Randomised controlled study of conjunctival autograft versus amniotic membrane graft in pterygium extraction. Br J Ophthalmol. 2006;90:1476–1480
  36. Küçukerdönmez C, Akova YA, Altinörs DD. Comparison of conjunctival autograft with amniotic membrane transplantation for pterygium surgery: surgical and cosmetic outcome. Cornea. 2007;26:407–413
  37. Ma DH, See LC, Hwang YS, Wang SF. Comparison of amniotic membrane graft alone or combined with intraoperative mitomycin C to prevent recurrence after excision of pterygium. Cornea. 2005;24:141–150
  38. Ye J, Kook KH, Yao K. Temporary amniotic membrane patch for the treatment of primary pterygium: mechanisms of reducing the recurrence rate. Graefes Arch Clin Exp Ophthalmol. 2006;244:583–588
  39. Lewallen S. A randomized trial of conjunctival autografting for pterygiumin the tropics. Ophthalmology. 1989;96:1612–1614
  40. Tan DT, Chee SP, Dear KB, Lim AS. Effect of pterygium morphology on pterygium recurrence in a controlled trial comparing conjunctival autografting with bare sclera excision. Arch Ophthalmol. 1997;115:1235–1240
  41. Fernandes M, Sangwan VS, Bansal AK, Gangopadhyay N, Sridhar MS, Garg P, et al. Outcome of pterygium surgery: analysis over 14 years. Eye. 2005;19:1182–1190
  42. Tseng SC, Espana EM, Kawakita T, Di Pascuale MA, Li W, He H, et al. How does amniotic membrane work?. Ocul Surf. 2004;2:177–187
  43. Tseng SC, Li DQ, Ma X. Suppression of transforming growth factor-beta isoforms, TGF-beta receptor type II, and myofibroblast differentiation in cultured human corneal and limbal fibroblasts by amniotic membrane matrix. J Cell Physiol. 1999;179:325–335
  44. Shimmura S, Shimazaki J, Ohashi Y, Tsubota K. Antiinflammatory effects of amniotic membrane transplantation in ocular surface disorders. Cornea. 2001;20:408–413

PII: S1367-0484(07)00130-0

doi: 10.1016/j.clae.2007.11.004

Contact Lens & Anterior Eye
Volume 31, Issue 2 , Pages 73-80 , April 2008

Article Tools

* Image Usage & Resolution